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I am delighted to welcome this – the first progress
report of the National Advisory Committee on
Drugs (NACD) – since it was established in 2000.
The NACD fulfils the very important role of
advising Government in relation to prevalence,
prevention, treatment and consequences of
problem drug use in Ireland. The Committee is
overseeing the delivery of a three-year research
programme aimed at addressing the priority
information gaps and deficiencies in the area of
drug misuse in Ireland. Research is one of the four
pillars of the National Drugs Strategy 2001 – 2008
that clearly reflects the importance of having good
quality data and information underpinning policy-
making in this difficult and complex area. 
I am delighted that this Progress Report provides 
an opportunity to highlight the various research
projects that have been carried out – or are 
on-going – under the Committee’s stewardship.
I want to congratulate the Committee and its
Chairperson, Dr Des Corrigan, for the efficient and
professional manner in which it has carried out its
work to date. I also want to acknowledge the
strong commitment shown by members from across
the various sectors represented on the Committee.
The body of work produced to date is all the richer
for their input and expertise. 
I wish the Committee well in the future and look
forward over the coming months to seeing the
results of the many studies they have
commissioned. 
Noel Ahern TD
Minister of State with responsibility 
for the National Drugs Strategy
September 2003
FOREWORD
As Chairperson of the NACD, I am happy to present
this report covering the work of the Committee
from July 2000 to July 2003, to the Minister of State
with responsibility for the National Drugs Strategy, 
Mr Noel Ahern TD. This progress report details the
work undertaken by the NACD since July 2000. In
that short time we have achieved a lot and I hope
this report provides the public with an overview of
the crucial work that the NACD is charged with.
The members of the NACD have applied themselves
with great zeal and enthusiasm to the programme 
of work. The level of each member’s commitment 
is phenomenal and needs to be acknowledged. Over 
a three-year period, members have attended 28 full
committee meetings, each of which has lasted two
to three hours, with additional preparation time of
at least one hour for each meeting. Over and above
the Committee meetings, the members have also sat
on two sub-committees each, with some members
also taking part in tender review teams and research
advisory groups. All in all, the Committee members
have each committed at least one full working day
per month to the NACD’s work. I thank them all for
this extraordinary input.
Other people have also made important
contributions to the Committee’s work. Clearly, 
the work of all of those involved in conducting the
research, as well as those who have assisted with it
in any way, deserve our gratitude. The work of our
colleagues in the Department, particularly Kathleen
Stack, demands special acknowledgement. Finally,
in this context, the support of the three Ministers
of State with responsibility for the National Drugs
Strategy with whom we have worked, former
Ministers of State, Chris Flood TD, and Eoin Ryan TD,
and the current Minister Noel Ahern TD, needs to
be publicly stated. Without their vision, tenacity and
commitment, the NACD would not have been able
to make the contribution we have to date.
All of this considerable body of work has been
achieved with extremely tight staffing, namely, a
Director and a Research Officer, aided and abetted
by two civil servants seconded by the Department.
Their single-mindedness and commitment to the
Committee’s work has been central to our
achievements.
Desmond Corrigan
September 2003
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This is the first report of the NACD on its research
activities from July 2000 to July 2003 inclusive.
When I took up the position of Director in July
2001, the Committee had already adopted its 
work programme, established the sub-committee
structures and with the support of the Secretariat
in the Department of Tourism, Sport and Recreation
recruited the first members of its team. By July
2001, the NACD had held 10 meetings, held several
sub-committee meetings and it had commissioned
three research projects.
In just three years we have completed 6 research
projects; we have initiated a further 19 research
projects with budgets ranging from €12,000 to
€650,000; we have 12 projects in various stages 
of development; and 2 more projects at concept
stage. These achievements are due largely to the
expertise and determination of our members and
staff. Through the commitment of past and present
members we have maintained the drive to bring 
an evidence-based approach to drugs policy 
and practice in Ireland. We have prepared the
foundations for supporting a research and
information era in drug policy development. 
As this report shows, the NACD has covered a
considerable amount of ground in a short period and
has already made a significant contribution to public
awareness on drugs issues as well as informing policy-
makers and everyone concerned with drugs misuse.
As is understandable, quite a significant portion of
time was spent establishing the body and its modus
operandi which is dealt with in Chapters One to
Three of this report, giving the background to the
Committee, its work programme and business plan.
Chapters Four to Seven then set out how the NACD
has executed the various elements of its business
plan up to July 2003. They deal with processes 
in place for planning and commissioning research,
how we have collaborated with other groups and
developed research capacity in Ireland on drugs.
Crucially, the report also sets out in some detail 
the research we have completed and that which 
we have in hand and gives a snapshot of what we
have found to date.
Looking to the future we are now preparing a new
three-year work programme. We are consulting
widely on this programme and welcome the views,
comments and suggestions of all those stakeholders
whom we serve. With a research base clearly pointing
to gaps in current knowledge we will reflect on all
these views when deciding priorities for the next
three years should we receive a renewed mandate. 
It is a privilege working with the NACD and its
Chairperson, Dr Desmond Corrigan, whose sense 
of fairness, openness and commitment has greatly
facilitated the work of the NACD. I sincerely thank
Aileen O’Gorman, Research Officer, Pat O’Grady 
and Muiris Ó Conchúir, former and current Office
Managers respectively, and Declan Crean,
Secretariat, for their hard work and dedication 
in achieving our goals.
Mairéad Lyons
Director
September 2003
EXECUTIVE SUMMARY 
1 European Monitoring Centre for Drugs and Drug Addiction.
Introduction
The NACD was established in July 2000 under the
auspices of the Department of Tourism, Sport and
Recreation to conduct, commission and analyse
research on issues relating to drugs and to advise
Government on policy development in the area.
Since June 2002, the NACD falls under the auspices
of the Department of Community, Rural &
Gaeltacht Affairs.
The establishment of the NACD followed a two-year
developmental phase during which an interim group
was convened to make recommendations and devise
a three-year work programme of research and
evaluation. The Government accepted these
recommendations and the NACD was established 
to implement the work programme.
The Committee reports to the Minister of State
with special responsibility for the National Drugs
Strategy and has a budget of €3.8 million over 
the three-year period to the end of 2003. Its goal 
is to advise the Government in relation to
prevalence, prevention, treatment/rehabilitation
and consequences of problem drug use in Ireland
based on its analysis of research findings and
information available to it.
What is the NACD?
Gathering information, developing knowledge 
and building understanding of why some people
develop drug problems and others do not is
essential. We need to know what to do, when 
to do it and how, if we are to make any difference
to the lives of people affected by drug misuse.
The NACD established a sub-committee structure
to facilitate the development and implementation
of its work programme. These sub-committees 
are listed below:
Consequences:
The impact of drug use on individuals, families and
communities
Early Warning Emerging Trends:
Linked to the EMCDDA1, alerts us to new synthetic
drugs and monitors trends in drug use
Prevalence:
How many people use drugs, what types of drugs,
at what age, and in what areas
Prevention:
Activities aimed at reducing drug use in the general
and specific population(s)
Treatment/Rehabilitation:
Activities aimed at changing or modifying behaviour
to reduce drug use, harm and prevent relapse
Composition
The membership of the NACD reflects the range of
different perspectives in the field of drug misuse.
The members serve at the invitation of the Minister
of State and have been drawn from the statutory,
community, voluntary and academic research
sectors together with senior level representation
from the relevant Government Departments. 
(For details of members see Appendix 1).
Chapter One
BACKGROUND TO THE NACD
N
A
C
D
Pro
gress Repo
rt July 2000 –
 July 2003
7
N
A
C
D
Pr
o
gr
es
s 
Re
po
rt
 Ju
ly
 2
00
0 
–
 Ju
ly
 2
00
3
8
Functions
The principal functions of the NACD are to:
• Review current information and research
capacity
• Identify gaps in our knowledge and
understanding
• Ensure better use of information available from
all sectors
• Provide analysis and interpretation of research
findings
• Respond to Government requests to research
issues of relevance to policy
• Work with the Drug Misuse Research Division
of the Health Research Board and assist with
the establishment of a National
Documentation Centre
• Implement the three year programme of
research and evaluation, liaising with all the
relevant agencies and avoiding duplication 
of work; co-ordinate and advise on appropriate
research projects; commission research projects
• Promote and encourage debate through the
dissemination of research findings.
Three Year Programme
The current work programme of the NACD, set out
below, has guided the actions of the Committee, 
its sub-committees and staff.
Inventory of Research and Information
• To compile a comprehensive inventory of
existing research, information and data sets
relating to the prevalence, prevention,
treatment/rehabilitation and consequences 
of drug misuse in Ireland
Improved Co-ordination of Research 
and Data Collection
• To open communication channels with key
agencies to ensure that the NACD is kept
informed of any new research being undertaken
or new data being collected
• To establish a research network which will
ensure better co-ordination and integration of
research projects among relevant agencies and
maximise resources in the context of the
NACD’s programme of research
The programme consists of the following elements:
Consequences
• To examine the impact of drug problems on
society in terms of: 
• drug related deaths
• the effect of drugs on the family and
communities
• the relationship between drugs and crime
• the methods for tackling social nuisance
related to drug misuse
Early Warning Emerging Trends
This group was originally set up in September 1997 
by the Department of Health as the ad hoc Early
Warning Committee on New Synthetic Drugs under
the 1997 Joint Action by the Council of the European
Union concerning information exchange, risk
assessment and control of new synthetic drugs where
each Member State had to set up a system of early
warning on the emergence of this phenomenon. In
2001, the committee was placed on a formal basis
within the NACD and its remit extended to include
the monitoring of emerging trends.
Prevalence
• To determine the size and nature of drug
problems in Ireland
• To determine the extent and nature of opiate
use, poly-drug use and patterns of drug use
(experimental, occasional, regular, non-medical
and problem use) particularly among young
people under 25
• To identify emerging trends and geographical
spread
• To determine the extent and nature of problem
use of prescription drugs
• To determine the prevalence of drug misusers
not in contact with treatment services
Chapter Two
WORK PROGRAMME
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Prevention
• To examine the effectiveness in terms of
impact and outcomes of existing prevention
models and programmes, with particular regard
to evaluation instruments developed at
European level
• To undertake comparative studies of different
models with particular reference to those in
operation in Local Drug Task Force (LDTF) areas2
• To determine transferability of models among
different target groups
Treatment/Rehabilitation
• To examine the effectiveness in terms of
impact and outcomes of existing treatment 
and rehabilitation models and programmes
• To examine the impact of the treatment setting
• To examine the context in which relapse occurs
• To undertake longitudinal studies of the
effectiveness of existing treatment and
rehabilitation models
2 Also in Regional Drug Task Force areas once these bodies have been established in each Health Board Area.
Once the office was established, the NACD set
about developing a Business Plan. As part of the
planning process, the NACD agreed the vision,
mission and values set out below. Each member 
and sub-committee were tasked with identifying
priority areas for research. These areas were then
agreed and budgets assigned to commission the
research. This plan was presented to the Minister 
of State in April 2002.
Vision
To provide a national focus for all knowledge
related efforts that inform Irish policy in relation 
to drug misuse.
Mission 
The NACD has undertaken to:
• Support the Government in significantly
reducing the health, social and economic
consequences of drug misuse through the
provision of timely data and analysis of
research
• Review its knowledge base, identifying gaps
which can be addressed through research
• Ensure that evidence from scientific research
forms the basis for policy formulation,
development of services and continuous
improvement in all its approaches to tackling
drug misuse in Ireland
• Work closely with the Drug Misuse Research
Division of the Health Research Board,
providing advice, co-ordinating research 
efforts and maximising the use of resources
• Support the establishment of a National
Documentation Centre
• Liaise with the relevant agencies nationally in
order to co-ordinate research and resources
• Ensure participation nationally of a broad range
of parties in fulfilling its research needs and
dissemination of findings
• Serve all drug misuse reduction activities in
providing for an effective dissemination of
research findings, information and other data
thus linking research to practice.
Values
The NACD agreed that the following values would
guide the implementation of its work programme.
The NACD will: 
• manage the diversity of its membership 
and commit to a consensus approach in
decision-making
• foster a culture of respect, dignity, transparency
and fairness in all its operations
• advocate dialogue as a means of balancing 
the diverse views on and experiences of drug
misuse in Ireland
• be objective in the collection and
dissemination of information in line with its
commitment to the National Drugs Strategy
2001-20083
• commit to the highest possible standards of
excellence and ethical conduct
• seek out collaborations and partnerships where
there is greater benefit to achieving its goal and
co-operate with everyone who can benefit
from its knowledge base.
Chapter Three
BUSINESS PLAN
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Sub-committee Actions
The Business Plan sets out a series of actions for
each sub-committee to undertake in the context 
of the NACD’s three-year work programme. The
sub-committees ensure that the following research
is undertaken either through direct commissioning
or in liaison with other agencies.
Consequences Sub-committee
1. Establish a research project that considers the
different stages of economic development,
regeneration projects, different community
experiences and variations in drug misuse.
2. Conduct comparative research with families:
changing roles; experience of multiple loss;
resilience and protective factors.
3. Develop research projects that would examine
housing and homelessness, drugs, crime and
neighbourhoods.
4. Research public health issues and their impact
on communities.
Early Warning Emerging Trends
1. Receive, share and monitor on behalf of the
NACD, information from National and EU
sources on New Synthetic Drugs of concern 
in the context of the Joint Action of 16th June
1997 concerning the information exchange, risk
assessment and control of new synthetic drugs
2. Receive, share and monitor on behalf of the
NACD, information on emerging trends and
patterns in drug use particularly poly drug use
and associated risks
3. Monitor the pilot project on emerging trends
being developed at EU level, to assess its
relevance to Ireland and whether it should 
be implemented in this country
4. Report to the NACD on a quarterly basis about
emerging trends and New Synthetic Drugs, but
more frequently if circumstances warrant it.
Prevalence Sub-committee
1. Review prevalence figures and current data
sources to identify research gaps.
2. Commission a second capture recapture study
to establish a National perspective and update
Comiskey Study of 1996.
3. Commission a network analysis study to
develop an Irish multiplier and benchmarks for
its application.
4. Commission a population survey on drug use
including alcohol and tobacco to establish
baseline data in line with EMCDDA standards
and drug misuse indicators.
5. Commission research into non-fatal overdoses
to inform overdose rate.
6. Establish a mortality rate amongst opiate users
in Ireland that can be comparable to other
countries.
7. Conduct a survey of third level students to
establish their drug use trends.
8. Commission a study of amphetamine use to
inform service development.
9. Assess prevalence of drug misuse amongst
vulnerable groups as highlighted in the 
National Drugs Strategy 2001-2008, Action 98
(see Appendix 4). 
Prevention Sub-committee 
1. Conduct research into family dynamic, types 
of family work currently underway and how 
we can build prevention into this work.
2. Explore the experience of practitioners on the
ground of interagency working from a
community and organisational perspective.
What were the enabling factors and what
caused resistance and conflict?
3. Examine the potential of media and marketing
tools to positively influence the way we view
drug misuse.
4. Follow the implementation of the SPHE (Social,
Personal and Health Education) to assess the
assimilation of the Walk Tall and On My Own
Two Feet elements of that programme.
5. Liaise with the National Drugs Strategy Team
(NDST)4 in relation to the co-ordination of
evaluation activities in the Local and Regional
Drugs Task Force (LDTF, RDTF) areas, in
particular with regard to prevention
programmes or new ideas being piloted.
Treatment Sub-committee
1. Conduct a Longitudinal Study on the
effectiveness of several treatment modalities 
as required in the National Drug Strategy 
2001-2008, Action 99 (see Appendix 4).
2. Conduct research into the management of dual
diagnosis and co-morbidity with particular
regard for service development and identifying
best practice.
3. Explore the phenomenon of poly-drug use and
implications for services.
4. Research the effectiveness of Buprenorphine as
a treatment intervention, a specific request of
the Minister of State with responsibility for the
National Drug Strategy.
5. Examine the needs of drug using young people
and implications for service delivery.
6. Review the treatment options for vulnerable
groups such as people who are homeless,
working in prostitution, have left school early
and the Traveller community to identify their
special needs.
7. Assess the quality of services in the context of
setting standards.
8. Research the effectiveness of new harm
reduction mechanisms for drug users as set out
in Action 100 of the National Drugs Strategy
2001-2008 (see Appendix 4).
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Commissioning research is a time consuming and
labour intensive exercise in any field of research.
Due to the complexity of researching drug issues/
addiction, a significant lead in time from 6 to 18
months is required in the preparation and
commissioning of the work. 
There are several stages to be followed in
commissioning research:
1. Agree the Research Question.
2. Agree the Design/Methodology Best Suited 
to Address the Research Question.
3. Prepare a Tender Brief.
4. Issue the Request for Tenders.
5. Award the Contract.
6. Agree Project Objectives Document.
7. Conflict of Interest.
1. Agree the Research Question
This is the most important phase. Clarity of
objectives is necessary for each stage in the
research process. In developing the research
question some background information is sought,
discussion of the issue takes place and finally the
objectives are agreed. The timescale for this phase
can be from two to six months.
2. Agree the Design/
Methodology
It is necessary at this stage to discuss the methods
most likely to address the research question. Issues
to consider for example are: the types of approaches
to be used – quantitative, qualitative, a combination
of both, ethnography, or other specialist approaches
such as using peer researchers. Understanding of the
ethical issues is critical at this stage. The timescale
for this phase can be from two to six months.
3. Prepare a Tender Brief
Once phase one and two are completed a tender
brief is prepared with the aim of giving as much
information as possible. Background information on
the NACD, the research project and requirements
for a tender submission are set out, together with
the criteria for selection of tenders. A project plan
is put in place outlining milestones, such as:
recruiting a selection panel; timescale for the
competitive process; assessment of the tenders;
interviewing of candidates if necessary and dates
for when contracts should be signed. 
4. Issue the Request for Tenders
The NACD observes the public procurement
policies of the Irish Government as set out by the
Department of Finance. The EU Services Directives
must be followed depending on the size of the
budgets. Tenders are placed on the e-government
website, on the NACD’s own website and are
occasionally advertised in the national press. Two
competitions were advertised in the Official Journal
of the European Communities (OJEC). The timescale
in this phase can slow down the process of
commissioning significantly, with a further four 
to six months for the tender competition needed
from advertisement to award of contract. 
5. Award the Contract 
In awarding the contract, the NACD reviews the
submissions against the criteria for selection and, if
necessary, shortlists the candidates. Interviews may 
be held, where presentations are expected to address
any information gaps for the tender review panel.
Once satisfied with the information supplied, the
NACD contract is awarded to the preferred bidder.
Chapter Four
PLANNING AND COMMISSIONING
RESEARCH
6. Agree the Project
Objectives Document
The NACD approaches all its research projects in a
standardised manner. Once the contract is awarded,
the contractor must then further develop or refine
the design in conjunction with a Research Advisory
Group (RAG) set up for each project. The RAG
provides a coaching and mentoring role, access 
to a varied network and expertise when needed.
The design is completed in the Project Objectives
Document, which becomes the research protocol
guide and a point of reference. The ethical issues
such as confidentiality and informed consent are
addressed in the project objectives document and
the contract. 
7. Conflict of Interest
The NACD has a diverse expert membership, many
of whom have an interest in research. In order to
manage the potential for a conflict of interest, rules
of procedure clearly set out members’ responsibility.
In addition, members and staff have fulfilled their
obligations under the Ethics in Public Office Acts
1995 and 2001. The Rules of Procedure can be found
on the NACD website www.nacd.ie.
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The NACD has been proactive in developing
collaborative approaches to implementing research.
Collaboration provides the benefit of building
networks, relationships and improving knowledge 
thus enhancing the quality of our work.
Population Survey
In October 2001, the NACD made contact with the
Drug and Alcohol Information and Research Unit
(DAIRU) in Northern Ireland to elicit their interest 
in collaborating on an all-island population survey
examining tobacco, alcohol and drug use.
Discussions continued over several months and an
agreement was reached in March 2002 to jointly
commission an all-island population survey on drug
use, including tobacco and alcohol. Substantial
resources have been committed by DAIRU
(€325,000) and the NACD (€375,000) to date.
Over 20 meetings have taken place thus far,
alternating between Belfast and Dublin, in the
planning, implementation and completion of this
project. The tender was widely advertised including
the OJEC and the contract was awarded in September
2002 to MORI MRC. MORI MRC have completed the
fieldwork, data entry and data cleaning. Over 8,000
people have been interviewed on the island of Ireland
– circa 3,500 in Northern Ireland and 4,900 in Ireland.
Analysis has started and key findings will be published
in Autumn 2003. The information exchange, sharing of
responsibilities and pooling of expertise has positively
impacted on this project. 
Homelessness and Drug Use5
The NACD has initiated other collaborative projects,
such as a prevalence study on drug use amongst
homeless people. As a first step, the NACD
contacted the key stakeholders to discuss its plans
and to ascertain the value of carrying out such 
work. Arising from these early discussions, the NACD
undertook a review of existing research on drug
misuse and homelessness in Ireland highlighting gaps
in our knowledge. This paper was presented at the
Merchants Quay Ireland (MQI) conference on
“Homelessness and Drug Misuse: Two Faces of
Exclusion” in Dublin Castle, July 2002. 
Following much interest, the NACD convened an
RAG of key stakeholders involved in the planning
and delivery of homeless and drug treatment
services to develop the research design and tender
brief for this study. The contract was awarded,
following a competitive tendering process, to the
Research Department of MQI. The NACD and the
RAG have worked closely with MQI to develop the
research questionnaire and the sampling strategy.
Over fifteen meetings have been held in the
development of this project to date. Fieldwork is
now well underway and the research 
is due to be completed by November 2003.
Chapter Five
COLLABORATIVE PROJECTS
5 This research study was requested under Action 98 of the National Drugs Strategy 2001-2008 (see Appendix 4).
Travellers and Drug Use Issues6
An exploratory study of drug use and drug issues
among the Traveller community has also been
commissioned. This project has been developed 
in collaboration with the key agencies working 
with Travellers. These agencies form the RAG for
this study and have been actively involved in the
research design, commissioning and monitoring 
of the project. The RAG meetings are facilitated 
by the NACD. Work to date includes pooling
information, sharing expertise, reviewing several
drafts of tender briefs, assessing tenders,
developing ethics applications, negotiating 
co-operation amongst the networks and facilitating
access to research participants. Over twelve
meetings have been held in relation to this project. 
Following ethical approval by the Traveller Ethics
and Information Working Group at the Department
of Health and Children, the project commenced in
June 2003. The research is due to be completed by
December 2003.
The National Drugs Awareness
Campaign
Developing a National Drugs Awareness Campaign is
Action 38 in the National Drug Strategy 2001-2008.
The Health Promotion Unit in  the Department of
Health and Children has responsibility for
implementing this action. The NACD is represented
on the committee convened to oversee the
commissioning of the campaign. The NACD
contributed to the tender brief, the review and
short-listing of tenders and the awarding of the
contract. Ongoing support was provided in the
preparation of materials and the provision of current
information and research. The first phase of the
campaign was launched in May 2003. The NACD 
has commissioned a research project to track the
effectiveness of this campaign over the three years.
The contract has been awarded to the Centre for
Health Promotion Studies, NUI Galway.
UK Research and Information
Working Group (RIWG)
The RIWG is facilitated by the Home Office in 
the UK with the purpose of bringing together the
devolved administrations of Scotland, Wales and
Northern Ireland to plan research strategies and to
administer allocated funding. However, the groups
soon became focused on sharing information and
exchanging ideas. Ireland was invited to participate
in March 2002. There are four meetings per year
alternating between venues and countries. The
NACD have attended all four in 2002. 
In 2003, two RIWG meetings have been held thus
far, one in Belfast hosted by DAIRU in March 2003
and one in Dublin hosted by the NACD in June
2003. Excellent networks and relationships have
been developed, which have enhanced the work 
of the NACD. NA
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Research Ethics – Guidelines
on Good Research Practice
Given the centrality of commissioning research 
to the NACD’s work, the Committee believed that
the provision of clear ethical guidelines for the
conducting of such research was an essential
foundation for its programme of work. In this
context, the NACD published a detailed paper
Research Ethics – Guidelines on Good Research
Practice.
The paper sets out a number of key principles for
researchers in relation to issues of consent, respect
for participants in any research, confidentiality and
researchers’ health and safety. The guidelines are
published on the NACD website www.nacd.ie.
Quality and Standards Seminar
The NACD organised a seminar, which took place in
November 2002, as part of the joint responsibilities
of the NACD and the country’s health boards to
“develop, in consultation with the NACD, criteria
to ensure that all State funded treatment and
rehabilitation programmes accord with quality
standards” as set out in Action 50 of the National
Drugs Strategy 2001-2008. The aim of the seminar
was to bring together the senior management
teams of the addiction services throughout the
country and discuss approaches to developing
quality standards. The seminar consisted of inputs
from five key speakers, followed by workshops on
different dimensions of quality standards in relation
to the provision of services to those involved in
drug misuse. Overall, there was very positive
feedback from participants. A report was prepared
and circulated within three months of the seminar
to everyone who was invited to attend. This report
is published on the NACD website.
Community And Voluntary
Sector Research Grant Scheme
Further to its work in conducting research into 
the consequences, prevalence, prevention and
treatment of drug misuse, the NACD decided 
in December 2001 to launch a Community and
Voluntary Sector Research Grant Scheme with the
aim of generating community-based drugs research. 
The scheme was developed to provide an ongoing
support mechanism to groups who were interested
in carrying out worthwhile research, but lacked 
the necessary expertise. A two-phase process,
which involved a combination of research training
and assessment, was set up to facilitate the
development of research proposals. Following 
this process, five community organisations were
awarded grants of between €20,000 and €25,000
at a reception hosted by the Minister of State in
September 2002.
The projects are monitored and supported by the
NACD Research Officer and Research Advisory
Groups which were established by each of the
community groups. Between five and ten meetings
have been held with each of the groups as part of
the NACD’s capacity building role. All projects will
be completed by the end of 2003.
The research grants were awarded as follows:
1. Ballymun Youth Action Project (BYAP)
BYAP is conducting a study of the role of
benzodiazepines (tranquillisers) in the development
of substance misuse problems in the Ballymun area
of Dublin. 
The research aims to investigate the relationship
between benzodiazepines, opiates and other
substances; describe the dynamics of benzodiazepine
supply and demand in local street drug markets;
examine the impact of benzodiazepine use on the
community; and identify the possible models of
Chapter Six
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prevention and harm reduction that might be
effective and appropriate in the community. 
Fieldwork has been completed and the project 
is at analysis stage.
2. Kilbarrack Coast Community
Programme (KCCP) 
KCCP is to carry out a survey of drug misuse among
10-17 year olds in the Kilbarrack area of Dublin. 
The study is seeking to establish the patterns and
trends of drug misuse in Kilbarrack by young people
in the 10 to 17 years age group; examine the
processes by which young people in the area
become involved in drug misuse; identify the
current and potential problems which arise from
their drug misuse; and assess the extent of
knowledge and attitudes of drugs and drug misuse
among young people. 
Fieldwork has been completed and the project is
now at analysis stage.
3. Community Response 
Community Response is to carry out a study of the
viability of an integrated multi-disciplinary service
to families affected by problem drug use in Dublin’s
southwest inner city.
The study will examine the impact of problem 
drug use on the family; identify the extent to 
which problem drug users rely on family members
and the extent of family resources used to support
them, document the needs of family members 
with a particular focus on women, and assess the
effectiveness of services and networks used by
families affected by problem drug use. 
Due to unforeseen circumstances the project was
discontinued in April 2003 and funding returned.
4. Merchants Quay Ireland (MQI) 
MQI is to carry out an exploratory study into 
the nature of drug use among three new ethnic
minority communities in Ireland. 
The study will examine the patterns of drug use
among the new communities and the routes of
administration of the drug(s) used; explore the
reasons and motivations for drug use; establish risks
the user may be exposed to; examine the level of
awareness of health promotion/harm reduction
strategies and drug treatment services; and identify
barriers to accessing services. 
Fieldwork has been completed and a report is
currently being prepared.
5. Tallaght Homeless Advice Unit (THAU)
The THAU will examine the links between
homelessness and drug use, especially heroin use, 
in the Tallaght area of Dublin. 
The research study will examine the nature and
extent of the drug use amongst the homeless
population and explore the reasons behind their
homelessness; examine the policies and practices 
of local authorities in relation to the housing of
homeless drug users; explore the experiences of
homeless drug users with special reference to the
policies and practices of homeless services; and
make recommendations aimed at informing policy
at government and practice level. 
Research is nearing completion with a draft report
already under review.
Conferences and Events
The NACD was represented at several conferences
throughout 2001, 2002 and 2003. These conferences
facilitated the exchange of up-to-date information,
pre-publication reviews of research and an
opportunity to discuss current research issues 
with the authors and other participants. The NACD
also hosted a number of events to release new
reports and to inform people on research activities.
Theses conferences and events are listed below in
date order:
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2001
June
“Economy, Culture and Community.” 1st Annual
Conference Addiction Research Centre, Trinity
College, Dublin.
September
“Science Meets Practice.” 44th International ICAA
(International Council on Alcohol and Addictions)
Conference on the Prevention and Treatment of
Dependencies. Heidelberg.
September
National Drugs Strategy Ministerial Information
Briefings to NAHB, ECAHB and SWAHB. Dublin.
October
European Society for Social Research on Drugs
(ESSD), 12th Annual Conference. Venice.
November
“Hit the Road Jack.” Issues for the Homeless Drug
User. Nurses Addiction Network (NAN) Conference.
Dublin.
November 
“Exclusion and Inclusion in Irish Society.” 28th
Annual Conference of the Sociological Association
of Ireland. Kerry.
December
NACD Launch of report “Drug Use Prevention – 
An Overview of Research”, Fitzwilliam Hotel, Dublin.
2002
February
International Scientific Conference on Cannabis
convened by Ministers of Public Health from
France, Belgium, Germany, the Netherlands and
Switzerland. Brussels.
March
“Meeting the Unmet Need – Reducing the Waiting
Time for Treatment.” 5th Annual General Practice
Conference on Opiate Misuse. Dublin.
March 
“Tackling Inequalities: Building Sustainable
Communities.” UKPHA (UK Public Health
Association) Annual Conference. Glasgow.
April
Citywide Conference on Family Support. Dundalk.
May
Combat Poverty Agency – Policy Seminar. Dublin
June
EMCDDA Semantics Differential Work Group
Meeting. Lisbon.
July
“Homelessness and Drug Misuse: Two Faces of
Exclusion.” Merchants Quay Ireland 1st Annual
Conference. Dublin.
September
“Debating Public Policies on Drugs and Alcohol.”
2nd Annual Conference Addiction Centre, Trinity
College, Dublin.
September
European Society for Social Research on Drugs
(ESSD) 13th Annual Conference. Helsinki.
September
“Drug Prevention in Europe.” Garda Síochána
Conference, Hippocrates EU Funded Programme.
Naas, Co. Kildare.
September
NACD Launch of the 5 Research Projects funded by
the Community and Voluntary Sector Research
Grant Scheme. Dublin.
October
NACD Launch of the report on the “Use of
Buprenorphine as an Intervention in the Treatment
of Opiate Dependence Syndrome”, Davenport
Hotel, Dublin.
November
NACD Information Briefing on the development 
of the first Research Outcome Study in Ireland
Evaluating Drug Treatment Effectiveness (ROSIE).
Mercer Hotel, Dublin.
November
NACD seminar on developing “Quality in Addiction
Services”. Mullingar.
2003
February 
Pompidou Group – (Co-operation Group to
Combat Drug Use and Illicit Trafficking in Drugs)
Seminar on Ethics, Professional Standards and Drug
Addiction. Strasbourg.
February 
NCPP – Towards a New Generation of Partnership;
delivering the Civil Service Change and
Modernisation Programme. Seminar: Dublin.
March
RIWG Seminar, Belfast.
May
NACD hosted a one day seminar on Approaches 
to Estimating Drug Prevalence in Ireland, Citywest
Hotel. Dublin.
June
Seminar on Drug Awareness Campaigns. British-Irish
Council. Dublin.
June
NACD hosted RIWG Meeting: Rationalisation
Seminar. Dublin.
July
EMCDDA Expert Meeting on Quality, Standards and
Data Collection in the field of social reintegration
in an enlarged European Union. Lisbon.
July
Health Impact Assessment – An Introductory
Seminar. Institute of Public Health in Ireland. Dublin.
July
Consultation Forum with non-Governmental
Organisations on Preparations for the 10th
Anniversary of the International Year of the Family.
Department of Social & Family Affairs. Dublin. 
Presentations
The Director and the Research Officer at the NACD,
as part of their briefs, disseminate the research
being conducted and research completed to key
audiences on an ongoing basis. Throughout 2001,
2002 and 2003 over 50 hours were contributed to
presentations across the country as follows:
2001
MSc Addiction Policy, Trinity College, Dublin.
SPHE7 Training Day, Dublin.
IDG8, Dublin.
NDST, Dublin.
Local Drug Task Force Co-ordinators, Dublin.
2002
Regional Drug Co-ordinators, Carlow.
MQI/UCD Certificate in Addiction Studies, UCD.
Midland Health Board Inter Agency Group,
Mullingar.
North Western Health Board, Inter-agency Group,
Donegal.
Addiction Studies Course, South Western Area
Health Board, Dublin.
Northern Area Health Board, Management Team,
Dublin.
East Coast Area Health Board, Management Team,
Dublin.
South Western Area Health Board, Management
Team, Dublin.
MA Addiction Studies, Dublin Business School.
Merchants Quay Ireland First Annual Conference
“Homelessness and Drug Misuse: Two Faces of
Exclusion.” Dublin.
Canal Communities Local Drug Task Force –
Seminar.
N
A
C
D
Pro
gress Repo
rt July 2000 –
 July 2003
217 Social Personal and Health Education.
8 Interdepartmental Group on Drugs.
N
A
C
D
Pr
o
gr
es
s 
Re
po
rt
 Ju
ly
 2
00
0 
–
 Ju
ly
 2
00
3
22
2003
One-Day Training Workshop for Short-listed
applicants to the Community and Voluntary Sector
Research Grant Scheme.
Addiction Studies Course – East Coast Area Health
Board, Dublin.
Interdepartmental Group on Drugs – National Drug
Awareness Campaign.
Questions and Answers Seminar – East Coast Area
Health Board, Bray.
Interdepartmental Group on Drugs –
Cocaine/Capture Recapture Studies.
DEWF – Work of NACD.
Research Training Workshop – Ballymun Youth
Action Project.
Information Briefing – Drug Use Among the
Homeless Research.
Masters in Addiction Studies – Dublin Business
School.
MQI Presentation on the Homeless – Central Hotel,
Dublin.
NACD Training
Project Management: Irish Times, all staff.
Media Training: Montague Communications. 
Five NACD chairpersons, two staff
Powerpoint Training: two staff
SPSS Training: two staff members
Computer Training MS Office: staff
National Documentation
Centre on Drug Use in Ireland
The establishment of a National Documentation
Centre (NDC) on Drug Use, to provide information
support on drug-related research to everyone 
who needs it in Ireland, was one of the key
recommendations of the Interim Advisory
Committee that preceded the NACD. The NACD 
has worked with the Drug Misuse Research Division
(DMRD) of the Health Research Board (HRB) to
establish the NDC, which opened in December 2002. 
A central element of this resource is the Electronic
Library of Irish related research material. This
comprises a bibliographical database with links to 
the full text of reports, conference papers, journal
articles, etc. Access to this electronic library is
available through the NDC’s website www.hrb.ie/ndc.
The NDC (which is based in Holbrook House, Holles
Street, Dublin 2) also holds a special library of drug-
related material, both published and unpublished.
The NDC has a team of three dedicated officers 
to maintain, develop and support the information
gathering and storing function of the NDC.
Many of the NACD research projects and
consultants have benefited greatly from the
availability of this important resource.
Since its establishment in 2001, the NACD has
completed a number of significant research
projects on:
1. Drug Use Prevention – An Overview of
Research
2. Use of Buprenorphine as an intervention in the
treatment of Opiate Dependence Syndrome
3. Consequences for Communities of Drug misuse
4. Overview of Research on Drug Use among the
Homeless in Ireland
5. Overview of prevalence information in Ireland.
6. A Capture Recapture study of opiate use in
Ireland
1. Drug Use Prevention – 
An Overview of Research 
Dr Mark Morgan from St Patrick’s College,
Drumcondra, undertook a review of national and
international literature in relation to drug use
prevention. The main conclusion of the report 
is that there is no single ‘drug problem’ with one
dramatic solution. 
Main Recommendations: 
• A need exists to prioritise certain substance
abuses over others, namely the more dangerous
ones such as opiates.
• Drug prevention policies should not ignore the
role that solvents, alcohol and tobacco play in
the overall scheme of things and policy should
not underestimate the symbiotic relationship
between illegal and legal drug use. 
• A distinction should be made between the
preventative measures aimed at occasional and
experimental use of cannabis and that of the
prevention of problem-use of other illegal
substances, which are associated with
deprivation. There is a need, however, for broad
based programmes focusing on experimental
drug use by young people from all social
backgrounds.
• Efforts to tackle serious drug use should firstly
concentrate on the social causes. 
• There is a need to work pro-actively with
families to prevent drug misuse by their children.
• There must be sufficient structural change in
Government Departments to facilitate high levels
of inter-agency co-operation on the matter.
• There is a need to integrate programmes that
deal with social exclusion.
• Professionals should complement the work
already carried out by teachers in their role in
primary drug prevention education.
• Schools should be encouraged to develop their
own drug prevention policies in line with the
recommendations of the National Drugs
Strategy (2001-2008).
• Journalists should have access to authoritative
information on drug problems and on
prevention specifically. 
• Finally, the report recommended that new ways
of using the mass media more effectively, in
the context of the National Drugs Strategy
(2001-2008), needed to be explored.
Chapter Seven
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2. Use of Buprenorphine 
as an Intervention in 
the Treatment of Opiate
Dependence Syndrome
This report was prepared by the National Medicines
Information Centre and the National Centre for
Pharmacoeconomics at St James’s Hospital, Dublin.
The research team was led by Dr Mary Teeling. 
The research was undertaken at the request of the
Minister of State, in 2001, on the effectiveness of
buprenorphine as a form of treatment for opiate
dependence.
Main recommendations
• Following this systematic review of
buprenorphine’s potential usefulness as an
intervention in the treatment of heroin
addiction, the NACD proposed to the
Government that buprenorphine should be
viewed as another effective treatment option
in the management of heroin addiction. It was
found that it has a better safety profile than
methadone.
• The review stated that the use of
buprenorphine might prove cost-effective in
selected Irish settings. The NACD recommended
that pilot studies be initiated in a range of
treatment settings, including GP surgeries. 
• The review pointed out that the use of
buprenorphine is not risk-free and should be
used in conjunction with non-drug treatments
such as counselling and other psycho-social
supports.
• The review indicated that the abuse potential
of buprenorphine is significant. The NACD
believe that this can be managed by using a
system of supervised dispensing.
3. Consequences for
Communities: a discussion
of the context and
consequences of community
drug problems 1976-2001 
Mr Barry Cullen of the Addiction Research Centre,
Trinity College, Dublin, conducted a literature
review and analysis of research and information
available in relation to the consequences of drug
misuse for families and communities. 
Given the dearth of appropriate research literature
on this topic in Ireland, Mr Cullen made a number
of recommendations on future research needs in
this area.
• In-depth evaluation of comparative treatment
outcomes, with particular attention to the
value of community-based treatment.
• In-depth research on the drugs-crime
relationship, with particular attention to the
impact of drug misuse, drug dealing and related
crime on local economies, and the social
embeddedness of drugs and crime within urban
neighbourhoods, and among specific groups
and families.
• One or two large comparative research projects
that examine the experience of Dublin within
the overall context of a suitable multi-city
research project.
• Young people’s exposure to and use of drugs
from within suburban environments, other
urban areas, particularly outside Dublin and
among particular groups, such as Travellers.
• Comprehensive analyses of community
responses to the drugs problem.
• Comparative research on families with drug
using and non-drug using members undertaken
from within an ecological model.
• Research on the relationship between drug
misuse and housing, paying particular attention
to the operation of local authority estate
management; the effects of new housing
legislation, especially as these relate to children
and families; and the social and health needs of
homeless drug users.
• Research that continuously and critically
examines the aims and performance of national
drugs policy. 
4. Overview of Research on
Drug Misuse among the
Homeless in Ireland
This overview was prepared by the NACD’s
Research Officer, Aileen O’Gorman. It explores the
links between drug use and homelessness, using
published Irish studies as a basis for the findings.
This report reviews the findings of five different
Irish studies concerned with the health problems 
of the homeless. It finds that:
• there are numerous studies published
concerning homelessness in Ireland however,
there is little evidence available concerning the
extent of drug misuse among this group 
• there is a need for service providers in both
homeless and drug treatment sectors to 
re-evaluate elements of the care they provide
for this marginalized group 
• there is a need for further research in this 
area to provide an informed view of the link
between drug misuse and homelessness in
order to implement relevant and effective
strategies. 
5. Overview of Prevalence
Information in Ireland
An overview of prevalence information in Ireland
was prepared by Dr Gemma Cox, Addiction
Research Centre, Trinity College, Dublin. Based on
recommendations contained therein, the Prevalence
Sub-committee commissioned research such as the
Network Analysis Study. A summary publication
based on Dr Cox’s report was published in 2003. 
6. A Capture Recapture Study
of Opiate Use in Ireland
A 3 source Capture Recapture Study of the
prevalence of opiate use in Ireland, 2000 to 2001
was completed in May 2003. This research was 
led by Dr Alan Kelly from the Small Area Health
Research Unit in Trinity College and his colleagues
Ms Marlen Carvalho and Mr Conor Teljeur. They
examined the prevalence of opiate use in Ireland
using three data sources:
• The Central Drug Treatment List (CDTL)
• The National Garda Study on Illicit Drug Use
and Related Criminal Activity
• The Hospital In-Patient Enquiry database (HIPE)
The methodology used determines a prevalence
estimate based on identifying the number of
individuals in each data source and the overlap 
of those appearing in one, two or three data sets.
The numbers are then modelled using a statistical
technique to provide an estimate.
Overall, it is estimated that in 2001, 14,452 people
were using heroin in Ireland. When the figures for
Dublin only were extracted and the statistical
technique reapplied it showed there were 12,456
people using heroin aged between 15 and 54
years. This compares favourably with the 1996
figure of 13,461.
The most significant changes appear to be in the
aging profile of heroin users. There are fewer young
people aged 15-24 using opiates, a phenomenon
that will need to be investigated further. Whilst
there are more heroin users in the age group 25-34
and 35-44 than in 1996. This can be attributed in
part to changes in the population over time but
also to the improved availability of drug treatment
services.
The results are available on the website and were
presented at a Seminar in May 2003 on Approaches
to Estimating Drug Prevalence in Ireland. A
publication will be available in Autumn 2003. 
Dr Kelly and his team are testing the feasibility of
presenting estimates at a local level to Local Drug
Task Forces using the figures currently available to
them. 
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Consequences
Cannabis Overview
The NACD has commissioned an overview of the
scientific information on cannabis to inform
knowledge regarding the use of cannabis. This study
is being carried out by a number of researchers – 
Dr Mark Morgan (St Patrick’s College, Drumcondra),
Mr Johnny Connolly (Independent Researcher)9, 
Dr Dominque Crowley (UCD) and Dr Claire Collins
(UCD).
The areas that will be covered include:
• Pharmacotoxicological information
• Psychological effects on cognition, mood and
mental functioning
• Sociological/criminological information
• Public health risks: epidemiological information,
physical and mental health and performance
impairment.
A comprehensive document has been prepared and
is nearing completion. Publication is expected by
the end of 2003.
Community Study
The NACD commissioned a study to  examine how
communities’ experiences of the drug situation has
changed since 1996. This study is being carried out by
Dr Hilda Loughran and Dr Mary Ellen McCann (UCD).
The study will explore the experiences of three
communities and develop indicators of a
community drug problem. The study will describe
the various initiatives that have been developed 
in the intervening years and the communities’
influence on these initiatives. The study will also
focus on the lessons that have been learned and
how these may influence future development in
similar communities.
Three communities have been selected and a
research team has been recruited. Training has been
provided and secondary data collection initiated.
The project is of two years duration and not
expected to finish before December 2004.
Impact of Drug Use on Families
The NACD commissioned a scoping study to
investigate the information gaps and research 
needs regarding the impact of drug use on families.
Dr Kieran McKeown was contracted to carry out
this small study in collaboration with the Family
Support Network of the Dublin Citywide Drugs
Crisis Campaign. A paper was presented to the 
sub-committee for consideration. Discussions are
on-going and a project is unlikely to commence
before conclusion of the prevention family support
services study.
In addition to the research
already published, the NACD
has commissioned a number 
of other studies, due for
publication during 2003.
Chapter Eight
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9 Now employed by DMRD in HRB.
Prevalence
Capture Recapture Study
(see Chapter 7)
Network Analysis Study
The brief of this study is to conduct a network
analysis of opiate users and to provide information
on the nature of their drug use. It is being
undertaken by Dr Jamie Saris and Dr Catherine
Comiskey, NUI Maynooth. A sample of 150 opiate
users is being surveyed, with 40 opiate users
participating in further in-depth interviews.
The issues being examined include drug treatment,
drug related offences (types) and overdoses, all of
which will assist in establishing benchmarks and
multipliers. The multiplier can then be applied 
to the benchmark such as the number of those 
in treatment and an estimate of prevalence can 
be produced. The in-depth analysis will provide
additional information on all aspects of opiate use
from the amount of heroin used, the method of
ingestion, its cost and availability.
Progress has been good with new and interesting
information emerging. The fieldwork has been
completed. Analysis of preliminary findings is
underway, with a progress report expected in
October 2003.
General Population Study
(See Chapter 5)
Cocaine Review
The NACD conducted an assessment of cocaine use
in Ireland. The research analysed Irish statistics on
cocaine gathered from a number of sources including:
• Local community feedback
• Garda Síochána and Customs and Excise
statistics under the Misuse of Drugs Act
• Drug Test Analysis from the laboratory located
in the Drug Treatment Centre Board and the
Medical Bureau for Road Safety
• Data from the National Drug Treatment
Reporting System
• Survey of cocaine users through UISCE10 and
Merchants Quay Ireland.
A report was submitted to Government in April
2003 outlining a review of available literature on
treatment and prevention and an analysis of the
information gathered in Ireland. Publication is due
in October 2003.
Key findings are showing upward trends in seizures
and consumption. Numbers attending for treatment
are small when compared with heroin but increasing.
Growing numbers of heroin dependent drug users are
also using cocaine. There is no drug of substitution in
the management/treatment of cocaine. Most
effective treatments are structured Cognitive
Behavioural Therapy (CBT) type programmes.
Prevention
Family Support Study
A study exploring the contribution of family support
services to drug use prevention is currently being
carried out by Unique Perspectives, an independent
research company. This study will build on the work
of Dr Mark Morgan on drug use prevention
strategies and on Dr Kieran McKeown’s review of
family support services in Ireland (see below).
The research will examine the extent to which
current services explicitly identify drug problems 
as a target of their activities; the extent to which
family support work (that is both work done by
drug agencies and general family support work
which does not explicitly identify drug issues as
one of its targets) may be judged to play a role in
the prevention of drug problems; and the potential
of expanding the scope of family support so as to
enhance its capacity with regard to drug
prevention.
An RAG supports and monitors the project. A draft
report is due in Autumn 2003.
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Treatment
National Longitudinal Study
Dr Catherine Comiskey is leading a team from 
NUI Maynooth, in collaboration with the Centre 
for Drug Misuse Research in Glasgow, to carry out 
a longitudinal study evaluating drug treatment
effectiveness. The study will be known as ROSIE
(Research Outcome Study in Ireland Evaluating Drug
Treatment Effectiveness) and will be a large-scale
project, similar to the UK’s National Treatment
Outcome Research Study (NTORS). The research,
which will be completed by late 2005, will involve
a sample of around 500 drug users.
The research instrument has been designed and
tested in a pilot study. The findings were reported
on and reviewed by the RAG. Some adjustments
were made. ROSIE will begin in August 2003.
Dual Diagnosis
This is a study to examine the structures of mental
health and addiction services and how they
experience and manage dual diagnosis (i.e. the
simultaneous presence of both an addiction and 
a mental health disorder). This study will be 
carried out using both national and international
comparisons. A team from Dublin City University
(DCU) School of Nursing, led by Mr Liam
MacGabhann, is carrying out the research.
A research instrument has been designed, tested
and implemented. Both qualitative and quantitative
approaches have been used. Findings are expected
in November 2003.
Harm Reduction
A literature review on harm reduction approaches 
is being carried out by a team from DCU School 
of Nursing, led by Mr Gerard Moore. This is aimed
at exploring ways of minimising the harm from 
the sharing of equipment used to take drugs. The
report is now in the final stages of completion and
will be considered by the NACD in Autumn 2003.
Other Treatments
Two reports, one on Lofexidine and the other on
Naloxone reviewing their use in managing opiate
dependency have been undertaken by the National
Medicines Information Centre, St James’s Hospital,
Dublin. The reports are at publication stage and will
be circulated in Autumn 2003.
Consequences 
Public Health Issues
The sub-committee have been examining the public
health issues relating to drug use and their impact
on communities. Several meetings have been held
with community groups and statutory services to
illicit information on defining the most problematic
public health issues. These have been predominantly
HIV/AIDS and Hepatitis C. Some communities are
experiencing the problem to a greater degree than
others and we are interested in exploring this
further. Development of this research is ongoing.
The report on Harm Reduction may be particularly
helpful to the development of research in this area.
Drugs, Crime and Neighbourhood
Drugs, crime and neighbourhood issues have not
received priority pending discussions with the
National Crime Council on its research plans and
priorities. The NACD is actively collaborating with
the Garda Research on Illicit Drug Use and Related
Criminal Activity.
Early Warning Emerging Trends
Risk Assessments
As part of its work programme, the sub-committee
has commented on the 6 risk assessment excercises
conducted by the EMCDDA. These assessments
included a toxicological report, a review of the
social aspects of its use and its availability on the
market for each of the following compounds:
• MDMD (ecstasy analogue)
• GHB (gammahydroxybutyrate)
• Ketamine
• 4MTA
• PMMA
• 2C-1, 2C-T-2, 2C-T-7
• TMA-2.
Data Collection
The committee is currently discussing how it 
will meet the objectives of the Programme for
Government and the National Drugs Strategy
regarding the identification of new drug trends 
such as the spread of heroin into new areas. The
Research Officer has prepared a briefing paper on
models of emerging trends monitoring systems to
inform these discussions.
Prevalence
Drug Use Among Third Level Students
The Prevalence Sub-committee has expressed a
need to examine drug use trends amongst third
level students and also to examine the trends in
using amphetamines. It was decided to await the
results of the population survey before planning
further research on these issues. A small sample 
of third level students will be captured in the
population survey. The NACD is liaising with the
relevant bodies in establishing what information is
available to it for consideration. Specific questions
on amphetamine use are asked of all respondents 
in the population survey. Detailed analysis of the
population survey findings will provide us with
information relevant to these issues in 2003.
Non Fatal Overdoses
Some preliminary discussions have been held with
ERHA11 and an A&E12 consultant regarding conducting
research in A&Es to determine the level of non-fatal
overdoses. Due to ongoing research activities within
A&Es, it was decided to defer developing this project
to the next triennial programme.
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Mortality Rates
Mortality rates of opiate users in Ireland need 
to be established together with a clear definition 
of drug related death. Several discussions and
meetings have been held on this issue and the
process is ongoing.
Vulnerable Groups
The National Drugs Strategy 2001-2003 requested
the NACD examine the issue of drug use among
vulnerable groups such as homeless people,
Travellers, early school leavers and sex workers.
Studies on drug use among homeless people and
the Traveller community are now underway.
Literature reviews of existing studies on early
school leavers and sex workers is in progress, these
will help shape the development of research
proposals regarding drug use among these groups.
Prevention
Inter-agency work
A review of literature will be undertaken in 2003 of
Irish-based reports and evaluations of interagency
working, partnership processes across agencies and
sectors and collaborative processes. The Irish
evidence needs to be collated before we can plan
an appropriate research project or NACD action.
This data gathering is underway.
Social, Personal & Health Education (SPHE)
The Prevalence Sub-committee and the NACD liaise
with the SPHE programme through its members and
also through participation on committees within
the Department of Education & Science. We are
awaiting the report on an evaluation of SPHE
commissioned by that Department.
Evaluations
In 2002, a preliminary meeting was held with the
NDST to explore the issue of conducting evaluations
of interventions and projects. This process is ongoing.
Treatment 
Poly Drug Use
Increasingly, the NACD has become aware that 
poly drug use is more and more common and is
one of the destabilising factors in any treatment 
or rehabilitation process. It is anticipated that the
population survey will provide information about
poly drug use within our society. The ROSIE study
will be able to capture poly drug use among its
research participants accessing treatment and
highlight the implications for treatment
effectiveness over time.
Under 18s and Treatment
The NACD is represented, through its Research
Officer, on a special committee exploring the
treatment needs of young people. This committee
is convened and chaired by the Department of
Health & Children and has commissioned some
preliminary research on the issues.
(includes VAT
where applicable)
Consequences
Cannabis Overview
Dr Mark Morgan €9,050.80
Ms Claire Collins €9,663.06
Mr Johnny Connolly €5,929.00
Community Study
Dr Mary Ellen McCann/
Dr Hilda Loughran, UCD €121,000.00
Consequences for Communities 
of Drug Misuse 
Mr Barry Cullen, TCD €9,903.96
Scoping Study on Family Research
Dr Kieran McKeown €4,840.00
Prevalence
Capture/Re-capture Study
Dr Alan Kelly, TCD €25,096.61
Drug Use amongst Homeless People
Merchants Quay Ireland €64,000.00
Drug Use amongst the 
Traveller Community
Vision 21 €60,000.00
Network Analysis Study
Dr Jamie Saris & Dr Catherine 
Comiskey, NUI, Maynooth €131,447.00
Population Survey
MORI/MRC €649,770.00
Review of Prevalence Information
Dr Gemma Cox, TCD €7,618.00
Editing: Ms Marie Lowe €2,926.00
Approaches to Estimating Drug 
Prevalence in Ireland – Publication €6,800.00
Cocaine Review €10,000.00
Prevention
Prevention Report
Dr Mark Morgan €8,500.00
Publication of Report €24,500.00
Family Support Study
Unique Perspectives €68,365.00
(includes VAT
where applicable)
Treatment
Buprenorphine Report
NMIC, Dr Mary Teeling €37,139.45
Publication €6,850.00
Dual Diagnosis
Mr Liam MacGabhann, DCU €60,500.00
Harm Reduction
Mr Gerry Moore, DCU €14,520.00
Lofexidine and Naloxone Reviews
NMIC, Dr Mary Teeling €12,000.00
Longitudinal Study
Dr Catherine Comiskey & 
Dr Gloria Crispino-O’Connell, 
NUI, Maynooth €634,887.00
Quality Seminar €5,093.49
Community and 
Voluntary Sector 
Research Grant Scheme
Ballymun Youth Action Project €25,000.00
Community Response €20,000.00
Kilbarrack Coast Community Programme €25,395.00
Merchants Quay Ireland €25,395.00
Tallaght Homeless Advice Unit €25,395.00
Supporting 
Actions/Activities
PR/Communications
Montague Communications 
(over 18 months) €83,490.00
Total Allocated €2,180,957.37
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Chairperson
Dr Des Corrigan, School of Pharmacy, Trinity College
Vice Chairperson
Dr Mary Ellen McCann, Voluntary Drug Treatment
Network 
Members
Dr Joe Barry, Eastern Regional Health Authority 
Mr Willie Collins, Southern Health Board
Mr Tony Geoghegan, Irish Association of Alcohol 
& Addiction Counsellors (IAAAC)
Dr Derval Howley, National Drugs Strategy Team
Mr David Keenan, Voluntary Drug Treatment Network
Dr Eamon Keenan, Consultant Psychiatrist, Eastern
Regional Health Authority
Mr David Moloney, Department of Health and
Children
Supt Barry O’Brien, Garda National Drugs Unit
Mr Liam O’Brien, Community Sector
Mr Barry O’Connor, Department of Justice, 
Equality & Law Reform
Dr Máirín O’Sullivan, Department of Education 
& Science
Ms Anna Quigley, Community Sector
Dr Hamish Sinclair, DMRD, Health Research Board
Ms Kathleen Stack, Drugs Strategy Unit, Department
of Community, Rural & Gaeltacht Affairs
Former NACD Members
Mr Billy Byrne, Department of Justice, Equality 
& Law Reform
Dr Shane Butler, Trinity College.
Mr Jimmy Connolly, IAAAC
Mr Gary Broderick, Voluntary Drug Treatment
Network
Dr Mark Morgan, St Patrick’s College, Dublin 
Dr Louis O’Carroll, Eastern Regional Health
Authority
Fr Seán Cassin, Voluntary Drug Treatment Network
Ms Ruby Morrow, Department of Education 
& Science
Ms Kate Ennals, Combat Poverty Agency
Ms Mary Jackson, Department of Health & Children
Mr Jimmy Duggan, Department of Health &
Children
Mr Tom Gilsen, Community Sector
Ms June Meehan, Combat Poverty Agency
Ms Rosalyn Moran, DMRD, Health Research Board
Ms Mary O’Brien, DMRD, Health Research Board.
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1. Consequences:
Ms Irene Kirwan
Drug Strategy Unit, Department of Community,
Rural & Gaeltacht Affairs
2. Early Warning/Emerging Trends:
Ms Lylia Crossan
Crime Division, Department of Justice, Equality 
& Law Reform
Ms Pauline Leavy
Medical Bureau of Road Safety, University College
Dublin
Det Garda Pat Davis
Garda National Drug Unit, “C” Branch, Dublin Castle, 
Ms Siobhan Stokes
State Laboratory, Abbotstown, Co Dublin
Dr Daniel O’Driscoll
Head of Drugs Unit, The Forensic Science
Laboratory, Department of Justice, Equality 
& Law Reform
Mr Tom McGuinn
Department of Health & Children
Ms Anya Pierce
Toxicology Department, Beaumont Hospital, Dublin
Mr John Kelly
Drug Strategy Unit, Department of Community,
Rural & Gaeltacht Affairs
3. Prevalence:
Dr Alan Kelly
Department of Community, Health and General
Practice, Trinity College, Dublin
4. Prevention:
Ms Elaine Butler
Drug Education Workers Forum
Ms Olive McGovern
Health Promotion Unit, 
Department of Health & Children
Ms Ruby Morrow
Formerly of Department of Education & Science
and now Church of Ireland College of Education
5. Treatment:
Mr John Kelly
Drug Strategy Unit Department of Community,
Rural & Gaeltacht Affairs
Dr Íde Delargy
Irish College of General Practitioners (ICGP)
Ms Frances Nangle-Connor
Irish Prison Service (IPS)
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NACD Consequences EWET Prevalence Prevention Treatment
Dr Des Corrigan Sch Pharmacy TCD X X X X
Dr Mary Ellen McCann Voluntary Drug X X X
Treatment Network
Dr Joe Barry ERHA X X X
Mr Willie Collins SHB X X X X
Tony Geoghegan IAAAC X X X
Dr Derval Howley NDST X X X
Mr David Keenan Voluntary Drug X X X
Treatment Network
Dr Eamon Keenan ERHA X X X
Mr David Moloney Dept Health & Children X X X X
Supt Barry O’Brien Garda NDU X X X
Mr Liam O’Brien Community Sector X X
Mr Barry O’Connor Dept JELR X X X
Dr Máirín O’Sullivan Dept Education & Science X X
Ms Anna Quigley Community Sector X X X
Dr Hamish Sinclair Health Research Board X X X X X
Ms Kathleen Stack DSU, Dept Comm Rural X X
& Gaeltacht Affairs
Mr John Kelly DSU, Dept Comm Rural X X
& Gaeltacht Affairs
Ms Irene Kirwan Dept Comm Rural X
& Gaeltacht Affairs
Ms Lylia Crossan Dept JELR X
Ms Pauline Leavy UCD X
Det Garda Pat Davis Garda NDU X
Ms Siobhan Stokes State Laboratory X
Dr Daniel O’Driscoll Dept JELR X
Mr Tom McGuinn Dept Health & Children X
Ms Anya Pierce Toxicology Dept X
Beaumont Hosp
Dr Alan Kelly TCD X
Ms Elaine Butler Drug Workers Education X
Forum
Ms Olive McGovern Dept Health & Children X
Ms Ruby Morrow CICE Rathmines X
Dr Íde Delargy GP X
Ms Frances Irish Prison Service X
Nangle-Connor
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Ms Mairéad Lyons Director 
Ms Aileen O’Gorman Research Officer 
Mr Muiris Ó Conchúir Higher Executive Officer (Current Officer Manager)
Mr Declan Crean Clerical Officer 
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In the National Drugs Strategy 2001-2008, the
NACD was requested to undertake the following
actions.
98 To carry out studies on drug misuse amongst
the at-risk groups identified e.g. Travellers,
prostitutes, the homeless, early school leavers
etc. Including de-segregation of data on these
groups. It is essential that the individuals and
groups most affected by drug misuse and those
involved in working to reduce, treat and
prevent drug misuse have immediate access 
to relevant statistical information. 
99 To commission further outcome studies, within
the Irish setting to establish the current impact
of methadone treatment on both individual
health and on offending behaviour. Such
studies should be an important tool in
determining the long term value of this
treatment. 
100 To conduct research into the effectiveness of
new mechanisms to minimise the sharing of
equipment e.g. non-reusable syringes, mobile
syringe exchange facilities etc. to establish the
potential application of new options within
particular cohorts of the drug using population
i.e. amongst younger drug misusers, within
prisons etc.
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